These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 701764)
41. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular disease. Serebruany V; Malinin A; Goodin T; Pashkow F Am J Ther; 2010; 17(2):125-32. PubMed ID: 20305399 [TBL] [Abstract][Full Text] [Related]
42. In vivo method for quantitation for anti-platelet potency of drugs. Gryglewski RJ; Korbut R; Ocetkiewicz A; Stachura J Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):25-30. PubMed ID: 652049 [TBL] [Abstract][Full Text] [Related]
43. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery]. Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025 [TBL] [Abstract][Full Text] [Related]
44. The effect of aspirin on the exercise-induced changes in platelet function and blood coagulation. Davies T; Lederer DA; Davies JA; McNicol GP Thromb Res; 1974 Jul; 5(1):69-81. PubMed ID: 4610889 [No Abstract] [Full Text] [Related]
45. Heparin coupled to albumin, dextran and ficoll: influence on blood coagulation and platelets, and in vivo duration. Teien AN; Odegård R; Christensen TB Thromb Res; 1975 Aug; 7(2):273-84. PubMed ID: 1162648 [No Abstract] [Full Text] [Related]
46. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments. De Clerck F; Vermylen J; Reneman R Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914 [TBL] [Abstract][Full Text] [Related]
47. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806 [TBL] [Abstract][Full Text] [Related]
48. [Blood platelets and their role in hemostasis]. Lewandowska J Wiad Lek; 1974 Nov; 27(22):1965-9. PubMed ID: 4140618 [No Abstract] [Full Text] [Related]
49. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation. Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920 [TBL] [Abstract][Full Text] [Related]
50. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited. Alexander B Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500 [No Abstract] [Full Text] [Related]
51. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Clowes AW; Karnovsky MJ Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193 [TBL] [Abstract][Full Text] [Related]
52. [Current pharmacological aspects of antithrombotic drugs]. Stroescu V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):325-7. PubMed ID: 14367 [No Abstract] [Full Text] [Related]
53. Effects of reserpine on rabbit platelet aggregation and adherence to collagen or injured rabbit aorta. Cazenave JP; Reimers HJ; Packham MA; Mustard JF Biochem Pharmacol; 1977 Jan; 26(2):149-57. PubMed ID: 836333 [No Abstract] [Full Text] [Related]
54. Development of platelet contractile force as a research and clinical measure of platelet function. Carr ME Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942 [TBL] [Abstract][Full Text] [Related]
55. Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease. Hallén J; Atar D; Serebruany V Am J Ther; 2014; 21(2):91-8. PubMed ID: 19770797 [TBL] [Abstract][Full Text] [Related]
56. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy. Webster SE; Payne DA; Jones CI; Hayes PD; Bell PR; Goodall AH; Naylor AR J Vasc Surg; 2004 Sep; 40(3):463-8. PubMed ID: 15337874 [TBL] [Abstract][Full Text] [Related]
57. Fibrinogen interaction with human platelets: effect of other coagulation factors, prostaglandins and platelet inhibitors. Al-Mondhiry H; Ballard JO; McGarvey V Thromb Res; 1983 Aug; 31(3):415-26. PubMed ID: 20217998 [TBL] [Abstract][Full Text] [Related]
58. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration. Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985 [TBL] [Abstract][Full Text] [Related]
59. [Effect of drugs on blood platelet characteristics]. Zbinden G Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632 [No Abstract] [Full Text] [Related]
60. Inhibition of human and animal platelet adhesiveness to glass bead columns by adenosine, dipyridamole, chlorpromazine and acetylsalicylic acid. Fujitani B; Tsuboi T; Takeno K; Yoshida K; Shimizu M Thromb Haemost; 1976 Nov; 36(2):401-10. PubMed ID: 1036841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]